? SHARED RESOURCES MANAGEMENT The Ohio State University Comprehensive Cancer Center (OSUCCC) manages and supports 16 CCSG-funded Shared Resources (SRs) and is proposing two developing shared resources in this application. The goals of the OSUCCC SRs are to support OSUCCC members by providing specialized technologies, services, and expertise that maximize quality and speed of service, while maintaining cost-effectiveness and quality control. The SRs support all five Research Programs and are managed by faculty from seven different colleges and Nationwide Children?s Hospital. Most of the SRs are centrally located and in close proximity to OSUCCC members.
The Specific Aims for Shared Resource Management are to: 1) evaluate for need, and establish new specialized technologies, services and expertise that enhance scientific interaction and productivity; 2) ensure that the SRs provide cost-effective, reliable, and quality-controlled technologies, services and expertise; 3) support SRs through budget planning, laboratory management systems, and sustainability; and 4) establish policies for SR access and use. The OSUCCC directly manages 13 of the 16 SRs, and the others are jointly managed as institutional SRs that follow NCI policies. Reporting to the OSUCCC Director, the SRs are led by Sharyn Baker, PharmD, PhD, Associate Director for Shared Resources. Dr. Baker works with Heather Hampel MS, LGC, Associate Director for Biospecimen Research for integration of biospecimen services with the SRs. Dr. Baker leads the Shared Resource Team Leader (SRTL) committee that oversees SR management and implementation of the scientific vision. The SRTL monitors quality and user satisfaction through user surveys and user committees. SR development and evaluation is provided to Dr. Baker from the Associate Directors Committee, Program Leaders, and the External Scientific Advisory Board. Shared Resource Management operations include ensuring compliance with OSUCCC policies (prioritization of use and access, budgets, billing, and quality control) and compliance with OSU Office of Research policies and the federal Uniform Guidance. For the evaluation of new instrumentation and services, Dr. Baker manages the Intramural Research Program (IRP) that provides external peer review of SR applications, evaluating scientific merit and planned usage ($3.4M awarded this grant cycle. Overall support to the SRs over the last grant cycle has been $18M, allowing for all of the SRs to have been enhanced and offer new services. Future plans for each SR are accounting for planned increased usage due to the OSUCCC strategic research priorities and planned recruitment. The OSUCCC provides over $9M in overall support of the SRs annually, The OSUCCC is requesting a total of $1,971,340 in CCSG funding, 8.9% of the total support.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee H - Clinical Groups (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
United States
Zip Code
Fenn, J Daniel; Monsma, Paula C; Brown, Anthony (2018) Axonal neurofilaments exhibit frequent and complex folding behaviors. Cytoskeleton (Hoboken) 75:258-280
Zhang, Lingling; Yu, Jianhua; Wei, Wei (2018) Advance in Targeted Immunotherapy for Graft-Versus-Host Disease. Front Immunol 9:1087
Jasinski, Daniel L; Li, Hui; Guo, Peixuan (2018) The Effect of Size and Shape of RNA Nanoparticles on Biodistribution. Mol Ther 26:784-792
Gordillo, Gayle M (2018) Reply: Urinary Excretion of MicroRNA-126 Is a Biomarker for Hemangioma Proliferation. Plast Reconstr Surg 141:320e
Ott, Christopher J; Federation, Alexander J; Schwartz, Logan S et al. (2018) Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. Cancer Cell 34:982-995.e7
Brasky, Theodore M; Hinton, Alice; Doogan, Nathan J et al. (2018) Characteristics of the Tobacco User Adult Cohort in Urban and Rural Ohio. Tob Regul Sci 4:614-630
Saini, Uksha; Suarez, Adrian A; Naidu, Shan et al. (2018) STAT3/PIAS3 Levels Serve as ""Early Signature"" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube. Cancer Res 78:1739-1750
Olaverria Salavaggione, Gonzalo N; Duggan, Megan C; Carson, William E (2018) Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma. Melanoma Res 28:390-397
Jones, Caitlin E; Hammer, Anisha M; Cho, YouJin et al. (2018) Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland. Neoplasia 21:132-145
Benej, Martin; Hong, Xiangqian; Vibhute, Sandip et al. (2018) Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism. Proc Natl Acad Sci U S A 115:10756-10761

Showing the most recent 10 out of 2602 publications